New pill may stop vomiting from popular weight-loss drugs
NCT ID NCT06804603
First seen Nov 12, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tested whether tradipitant can reduce nausea and vomiting caused by GLP-1 receptor agonist drugs (like Ozempic or Wegovy) in 124 healthy overweight or obese volunteers. Participants received either tradipitant or a placebo, and tracked their symptoms daily. The goal was to see if tradipitant could help people tolerate these weight-loss medications better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanda Investigational Site
Los Angeles, California, 90025, United States
-
Vanda Investigational Site
Rochester, Minnesota, 55905, United States
-
Vanda Investigational Site
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.